Immobilized Recombinant Human CD79 (CD79A & CD79B Heterodimer) Protein (Flag & His Tag) (Cat#TMPY-05302) at 1 μg/mL (100 μL/well) can bind anti-CD79B (Polatuzumab biosimilar), the EC50 is 0.75-2.5 ng/mL (QC tested).

CD79 Protein, Human, Recombinant (Flag & His) is expressed in HEK293 mammalian cells with Flag and His tag. The predicted molecular weight is 37.5 kDa and the accession number is NP_001774.1&NP_000617.1.

Human

HEK293 Cells

MB-1,IGA,CD79a molecule, immunoglobulin-associated α,CD79a molecule, immunoglobulin-associated alpha

A DNA sequence encoding the human CD79A (NP_001774.1) (Met1-Arg143) was fused with a flag tag at the C-terminus, constructed the plasmid 1; A DNA sequence encoding human CD79B (NP_000617.1) (Met1-Asp159) was fused with a polyhistidine tag at the C-terminus, constructed the plasmid 2. The two plasmids were co-expressed and the human CD79A & CD79B heterodimer was purified. Predicted N terminal: Leu 33 & Ala 29

≥ 90 % as determined by SDS-PAGE. ≥ 85 % as determined by SEC-HPLC.

Reconstituted with sterile deionized water to 0.25 mg/mL. Reconstitution conditions may vary depending on the lot.

It is recommended to store recombinant proteins at -20°C to -80°C for future use. Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots.